News Editas Medicine, Inc.

Equities

EDIT

US28106W1036

Real-time Estimate Cboe BZX Other stock markets 12:02:38 2024-04-25 pm EDT			5-day change	1st Jan Change
5.215 ^USD	-2.52%		-7.03%	-49.06%

Mar. 13	Transcript : Editas Medicine, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 02:05 PM
Feb. 29	Barclays Adjusts Price Target on Editas Medicine to $11 From $10, Maintains Equal-Weight Rating	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting	Apr. 22	GL
Editas Medicine : April 2024 Corporate Presentation	Apr. 11	PU
Editas Medicine : Corporate Effectiveness Report April 2024	Apr. 11	PU
Transcript : Editas Medicine, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 02:05 PM	Mar. 13
Barclays Adjusts Price Target on Editas Medicine to $11 From $10, Maintains Equal-Weight Rating	Feb. 29	MT
Transcript : Editas Medicine, Inc., Q4 2023 Earnings Call, Feb 28, 2024	Feb. 28
Editas: Q4 Earnings Snapshot	Feb. 28	AQ
Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates	Feb. 28	GL
Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates	Feb. 28	AQ
Editas Medicine, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Editas Medicine, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 28	CI
Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor Events	Feb. 21	GL
Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor Events	Feb. 21	AQ
North American Morning Briefing : Stock Futures -2-	Feb. 21	DJ
Editas Medicine to Participate in Upcoming Investor Conferences	Jan. 31	GL
Editas Medicine to Participate in Upcoming Investor Conferences	Jan. 31	AQ
Transcript : Editas Medicine, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 04:30 PM	Jan. 09
Editas Medicine Highlights 2024 Anticipated Milestones and Strategic Priorities at the J.P. Morgan Healthcare Conference	Jan. 08	GL
Editas Medicine Highlights 2024 Anticipated Milestones and Strategic Priorities at the J.P. Morgan Healthcare Conference	Jan. 08	AQ
RBC Boosts Price Target on Editas Medicine to $11 From $8, Keeps Sector Perform Rating	Jan. 03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Editas Medicine, Inc.

Equities

EDIT

US28106W1036

Summary

Filters